Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapy.

Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapy.:

Related Articles

Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapy.

Radiother Oncol. 2020 Feb 13;:

Authors: Lowther NJ, Marsh SH, Louwe RJW

Abstract

BACKGROUND AND PURPOSE: Deformable image registration (DIR) facilitated dose reconstruction and accumulation can be applied to assess delivered dose and verify the validity of the treatment plan during treatment. This retrospective study used in silico deformations based on clinically observed anatomical changes as ground truth to investigate the uncertainty of reconstructed and accumulated dose in head-and-neck radiotherapy (HNRT).

MATERIALS AND METHODS: A planning CT (pCT), cone beam CT (CBCT) from week one of treatment and three later CBCTs were selected for 12 HNRT patients. These images were used to generate in silico reference CBCTs and deformation vector fields (DVFs) as ground truth with B-spline DIR. Inverse consistency (IC) of voxels was assessed by determining their net displacement after successive application of the forward and backward DVF. The reconstructed dose based on demons DIR was compared to the ground truth to assess the structure-specific uncertainties of this DIR algorithm for inverse consistent and inverse inconsistent voxels.

RESULTS: Overall, 98.5% of voxels were inverse consistent with the 95% level of confidence range for dose reconstruction of a single fraction equal to [-2.3%; +2.1%], [-10.2%; +15.2%] and [-9.5%; +12.5%] relative to their planned dose for target structures, critical organs at risk (OARs) and non-critical OARs, respectively. Inverse inconsistent voxels generally showed a higher level of uncertainty.

CONCLUSION: The uncertainty in accumulated dose using DIR can be accurately quantified and incorporated in dose-volume histograms (DVHs). This method can be used to prospectively assess the adequacy of target coverage during treatment in an objective manner.

PMID: 32063377 [PubMed - as supplied by publisher]